Patents
Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
03/2015
03/05/2015WO2015031598A2 Therapeutic dnp derivatives and methods using same
03/03/2015US8969330 Steroids as agonists for FXR
03/03/2015US8969328 Progesterone receptor antagonists
03/03/2015US8969327 Substituted androst-4-ene diones
02/2015
02/25/2015EP2838907A2 Aminosteroids for the treatment of a ptp1b associated disease
02/17/2015US8957055 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
02/17/2015US8956646 Zwitterionic lipids
02/03/2015US8946302 Selective sigma-1 receptor ligands
01/2015
01/29/2015US20150030541 Nanoparticle peg modification with h-phosphonates
01/27/2015CA2649175C Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
01/22/2015WO2015010054A2 Neuroactive steroids, compositions, and uses thereof
01/21/2015CN104302655A 甾醇衍生物和及其用于治疗牵涉转化的星形胶质细胞的疾病或治疗恶性血液病的用途 Sterol derivatives and their use for the treatment involves the conversion of astrocytes disease or therapeutic purposes hematologic malignancies
01/15/2015US20150018326 Compositions and methods for inhibiting norovirus infection
01/15/2015US20150018322 Pro-drug forming compounds
01/15/2015US20150017093 Radiolabeled bile acids and bile acid derivatives
01/13/2015US8933062 Nitric oxide releasing steroids
01/08/2015US20150011739 Tandem facial amphiphiles
12/2014
12/31/2014CN104254539A 抗糖尿病的氨基甾族化合物衍生物 Amino steroid derivative antidiabetic
12/25/2014US20140378645 Liquid crystal aligning agent
12/24/2014CN104232077A 基于胆固醇修饰的单芘荧光探针及其合成方法和应用 Based on cholesterol-modified single fluorescent probe and its synthesis method and application
12/24/2014CN104224799A 一种孕甾烷生物碱类化合物在制备抗菌药物中的应用 An pregnane alkaloid compounds in the manufacture of antibiotics in
12/10/2014CN102634334B 含芘双胆固醇型荧光探针及其合成方法和应用 Double cholesterol-containing fluorescent probes pyrene and its synthesis method and application
12/04/2014US20140356417 Modified drugs for use in liposomal nanoparticles
11/2014
11/18/2014US8889840 Vascular leakage inhibitor
11/11/2014US8884022 Inhibition of bacterial biofilms with aryl carbamates
10/2014
10/16/2014US20140309443 Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
10/16/2014US20140309417 Process for the preparation of sterol derivatives
10/09/2014WO2014164861A1 Onapristone polymorphic forms and methods of use
10/07/2014US8853190 Steroids having increased water solubility and resistance against metabolism, and methods for their production
10/02/2014US20140296510 Method for preparing ulipristal acetate and key intermediate thereof
09/2014
09/25/2014US20140288160 Cleavable lipids
09/23/2014US8841442 Process for preparing fluticasone propionate/furoate
09/23/2014CA2648537C Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil)
09/18/2014US20140274913 Methods for treating inflammation, autoimmune disorders and pain
09/18/2014US20140271819 Onapristone polymorphic forms and methods of use
09/15/2014CA2819448A1 Use of lxr antagonists for treatment of side effects of elevated glucocorticoid levels
09/11/2014US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative
09/10/2014EP2774933A1 Ulipristal acetate preparation method and intermediate thereof
09/04/2014US20140249122 Anti-diabetic aminosteroid derivatives
08/2014
08/27/2014EP2768840A1 Anti-diabetic aminosteroid derivatives
08/26/2014US8815263 Tandem facial amphiphiles
08/21/2014US20140235600 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
08/21/2014US20140235536 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicals
08/20/2014EP2767544A1 Amorphous substance of 17 -acetoxy-11 -(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione and preparation method thereof
08/14/2014WO2014122480A1 16- and 17- deuterated estrogen-3-sulfamates as estrogenic agents
08/13/2014CN103980338A 蟾蜍灵衍生物、其药物组合物及用途 Bufalin derivatives, pharmaceutical compositions and uses
08/13/2014CN103980337A 蟾蜍灵衍生物、其药物组合物及用途 Bufalin derivatives, pharmaceutical compositions and uses
08/13/2014CN102675673B 紫外光辅助的表面改性方法及具有由此方法形成的表面的制品 UV-assisted surface modification method and article having a surface formed by this method
08/13/2014CN102477060B 甾体化合物及其制备方法和用途 Steroidal compounds and their preparation and use
08/13/2014CN101861328B 作为心血管疾病所用药物的2-及/或4-经取代的雄甾烷和雄甾烯的氨基肟 As cardiovascular disease drugs used 2- and / or 4-substituted androstane and androstene-amino oxime
08/06/2014CN103965281A 一种原人参二醇衍生物、其制备方法及其应用 One kind protopanaxadiol derivatives, their preparation and their use
08/05/2014US8796248 Oligomer-corticosteroid conjugates
08/05/2014CA2677195C Industrial method for the synthesis of 17-acetoxy-11.beta.-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
07/2014
07/31/2014WO2014115170A1 Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
07/30/2014CN103958540A 神经活性类固醇、组合物、及其用途 Neuroactive steroids, compositions, and uses thereof
07/30/2014CN102659894B 一种六碳糖酯及其合成方法与用途 One kind of six-carbon sugar esters and synthetic methods and uses
07/29/2014US8790691 Modified drugs for use in liposomal nanoparticles
07/24/2014US20140206657 Bile acid analog tgr5 agonists
07/17/2014US20140200200 Antagonists of CB1 Receptor
07/16/2014EP2753632A1 Neuroactive steroids, compositions, and uses thereof
07/16/2014CN103923154A 醋酸乌利司他的共晶及制备方法 Ulipristal acetate eutectic and preparation methods
07/09/2014CN101921202B 1位取代的3,5-二氨基苯的制造方法 Method for producing a substituted 3,5-diamino-benzene
07/01/2014US8765695 Use of ginsenoside RG1, its metabolites ginsenoside RH1 and/or PPT
06/2014
06/25/2014CN103880909A 甾族化合物 Steroid
06/25/2014CN101568547B 作为17βHSD抑制剂的被取代的雌三烯衍生物 As 17βHSD inhibitors substituted derivatives of estratrienes
06/25/2014CN101466725B 作为心血管病症药剂的雄甾烷和雄甾烯的氨基衍生物 As a cardiovascular disorder agent of androstane and androstene-amino derivative
06/19/2014WO2014093378A1 Estrogen receptor imaging agents
06/19/2014WO2014091158A1 Testosterone derivatives with a carboxyalkyl substitution in position 3 and use thereof for the production of labelled steroids for determining the concentration of testosterone in a biological sample
06/18/2014CN102675672B Ultraviolet aided surface modification method and product with surface formed by method
06/17/2014US8754190 Controlled release from macromolecular conjugates
06/12/2014US20140162966 Nanoparticles for delivery of ligands
06/11/2014CN103848751A Ionizable cation lipid compound and application thereof
06/05/2014WO2014083512A1 Process for preparation of abiraterone acetate
06/05/2014WO2014083068A1 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone
06/04/2014EP2736918A1 Progesterone antagonists
06/04/2014CN103842370A Progesterone antagonists
05/2014
05/29/2014US20140148428 Treatment of Pulmonary Disease
05/21/2014CN103804458A 基于胆固醇的三种脂质材料的制备及其应用 Preparation and application of cholesterol-based lipid material in three
05/14/2014CN103787927A 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体 3-amino-1-propanesulfonic acid delivery methods, compounds, compositions, and vectors
05/07/2014CN103772469A 一种含有动物固醇和天然精氨酸结构片段的合成阳离子脂质、合成方法及其应用 An animal sterol synthesis of cationic lipid structure and natural arginine fragment containing the synthetic method and its application
05/07/2014CN103772468A 醋酸特拉司酮及其中间体的制备方法和用途 Preparation and use of acetic acid and intermediates Tel mifepristone
05/07/2014CN103772463A 2-甲氧基雌二醇类似物及其制备方法与用途 2-methoxyestradiol analogs and preparation method and uses
05/07/2014CN103768073A 具有双腙结构的甾体衍生物作为抗病毒药物的应用 Hydrazone derivative having a steroid structure as a double application of antiviral drugs
05/07/2014CN101679476B 23取代的胆汁酸作为tgr5调节剂及其使用方法 23 substituted bile acid as a modifier and the use tgr5
05/06/2014US8716270 Polymorphic and amorphous salt forms of squalamine dilactate
04/2014
04/30/2014CN103755765A Polycrystalline type for ulipristal acetate and preparation method thereof
04/30/2014CN103755764A Synthetic method of taurocholic acid
04/30/2014CN103755763A Preparation method of 17alpha-acetoxyl-11beta-(4-(N, N-dimethylamino)-phenyl)-19-norpregna-4, 9-diene-3, 20-diketone
04/30/2014CN102772418B Application of pachysamine/pachysandrine G
04/29/2014CA2664126C The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders
04/24/2014WO2014060888A1 Novel process and intermediate for preparation of ulipristal
04/24/2014WO2014059499A1 Preparation method and composition of a pharmaceutical drug from quenodeoxicholate linked to a natural, d-fructose-analogue, sulfamate-derived monosaccharide (topiramate) and to a phenylketone (bupropion) for the treatment of obesity and plurimetabolic syndromes
04/23/2014CN103739703A Glycocholic acid immunogen, anti-glycocholic acid specific antibody and detection reagent
04/22/2014US8703723 Glycoside compounds and pharmaceutical compositions thereof
04/17/2014WO2014058736A1 Neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
04/17/2014US20140107089 Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
04/16/2014CN103724392A Preparation method of amino acid phytosterol ester hydrochloride
04/16/2014CN102532236B Steroid 5Alpha-reductase inhibitors, preparation methods thereof and medical applications thereof
04/16/2014CN101822657B Pachysandra terminalis alkaloid compound for resisting tumor metastasis
04/03/2014WO2014050107A1 Crystalline polymorphic form of ulipristal acetate
1 2 3 4 5 6 7 8 9 10 11 ... 47